This underscores the importance of fungal stress responses in promoting pathogenesis and suggests that the development of drugs which target fungal SAPK pathways has the exciting potential to generate broad-acting antifungal treatments for human mycoses. The gene discussed is MAPK9; the disease is opportunistic mycosis.